New rapid Chlamydia test could enable 'test and treat' strategy

November 30, 2007

Wellcome Trust-funded researchers have successfully completed the clinical trial for a new rapid test for the sexually transmitted infection Chlamydia. The researchers believe the test, which is able to detect Chlamydia in less than 30 minutes – and often much faster – could be a valuable addition to screening programmes already in place, as well as providing a crucial diagnostic test in the developing world.

The new rapid test for Chlamydia has been developed by a team of researchers led by Dr Helen Lee at the University of Cambridge. An evaluation of the test in three UK clinics is reported in today's British Medical Journal. Dr Lee’s research teams at the university and their spin-out company Diagnostics for the Real World were recently awarded $50,000 as the winner of the 2007 Tech Museum Awards (USA) in the Health Category for the Signal Amplification System they developed, technology that underpins and improves the sensitivity of rapid tests.

Chlamydia trachoma is the world's most prevalent sexually transmitted bacterial infection. According to the Health Protection Agency, the number of diagnoses in the UK has risen steadily since the mid-1990s, reaching 110,000 in 2005. If left untreated, the disease can result in complications such as pelvic inflammatory disease, ectopic pregnancy and infertility. However, as up to 70% of infected women do not show symptoms, the disease often goes undiagnosed.

The new rapid test was developed to allow detection of Chlamydia using self-collected vaginal swabs, which is much easier to obtain than the cervical swabs required by existing rapid tests and is up to twice as accurate. The new Chlamydia rapid test detected infection in more than 4 out of 5 infected women, even though most showed no symptoms. This sensitivity is similar to some of the current gold standard nucleic acid amplification tests used in screening programmes, including in the UK. The rapid test can provide results in less than 30 minutes whilst the nucleic acid based tests can take weeks.

"The speed of the CRTs means that we can provide a 'test and treat' strategy, offering immediate clinical care to the patient," says Dr Lee. " This has the benefits of reducing the risk of complications and preventing onward transmission."

In addition to being a valuable addition to existing screening programmes, the new Chlamydia rapid test could be used in settings such as mobile clinics and outreach clinics to help improve the screening coverage of difficult-to-reach populations.

Penny Barber, Chief Executive of Brooks in Birmingham, a young people’s sexual health clinic which participated in the evaluation of the new test says: "The Chlamydia Rapid Test is about more than speed of treatment for positive clients, vital though that is from a public health perspective. All clients, anxious about having Chlamydia, benefit from the relief a rapid result gives. For clinics, there is a strong business case for a method that cuts out the logistics and cost of transporting samples, sending results back and then contacting clients."

In developing countries, especially those with high-risk populations such as female sex workers, the availability of this simple and rapid test would also allow screening and treatment of more individuals.

Dr. Lourdes Mahilum-Tapay, who led the clinical trials, comments: “Because the test is easy to use and is robust, it can be used in a clinic in London or the Philippines. The test can be implemented easily without the need for laboratory equipment or highly trained staff."

The Development of the test was made possible with funding from the Wellcome Trust's Technology Transfer Division. The test will be made available by the spinout company Diagnostics for the Real World in early 2008. They plan to provide the test at virtually cost price to public sections of the developing countries. This will be subsidised by charging the market price in the developed world.

Source: Wellcome Trust


Rank 5 /5 (1 vote)
Tags

Relevant PhysicsForums posts
  • Can I forget a language?
    created2 hours ago
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Researchers develop new method for creating tissue engineering scaffolds

Researchers at Northwestern University have developed a new method for creating scaffolds for tissue engineering applications, providing an alternative that is more flexible and less time-intensive than current technology.

Medicine & Health / Research

created 38 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Drug halts organ damage in inflammatory genetic disorder

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease ...

Medicine & Health / Medications

created 49 minutes ago | popularity not rated yet | comments 0

Molecular profiling reveals differences between primary and recurrent ovarian cancers

There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...

Medicine & Health / Cancer

created 38 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Health experts, scientists to discuss bird flu studies

The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.

Medicine & Health / Diseases

created 14 minutes ago | popularity not rated yet | comments 0

Cochlear implants may be safe, effective for organ transplant patients

Cochlear implants may be a safe, effective option for some organ transplant patients who've lost their hearing as an unfortunate consequence of their transplant-related drug regime, researchers report.

Medicine & Health / Other

created 47 minutes ago | popularity not rated yet | comments 0 | with audio podcast


Hovering not hard if you're top-heavy, researchers find

Top-heavy structures are more likely to maintain their balance while hovering in the air than are those that bear a lower center of gravity, researchers at New York University's Courant Institute of Mathematical Sciences ...

Grass to gas: Researchers' genome map speeds biofuel development

Researchers at the University of Georgia have taken a major step in the ongoing effort to find sources of cleaner, renewable energy by mapping the genomes of two originator cells of Miscanthus x giganteus, a large perenn ...

C-sections linked to breathing problems in preterm infants

Research conducted at Yale School of Medicine shows that a cesarean (C-section) delivery, which was thought to be harmless, is associated with breathing problems in preterm babies who are small for gestational age.

Review: Netflix and Hulu's new scripted originals

Within just over a week, Netflix and Hulu are both debuting their first stabs at original scripted programming.

India probes Google over 'forex transactions'

Indian authorities are probing whether online giant Google broke domestic foreign-exchange transactions rules while shifting funds abroad, the Press Trust of India reported on Friday.

Germany freezes signing of disputed Internet pact

Germany on Friday halted the signing of a controversial international accord billed as a way to beat online piracy that has sparked angry protests, saying it needed more time to consider it.